WELLS DAVID B 4

What Happened

• David B. Wells, a director of Hims & Hers Health, Inc. (HIMS), purchased 48,400 shares in open-market transactions on May 26, 2026. The filing reports an average weighted purchase price of $24.23 per share, for a total cost of approximately $1,172,974. This was a purchase (reporting code P), not a sale.

Key Details

• Transaction date: 2026-05-26 (reported timely).
• Price: average weighted price $24.23; purchases executed in the range $24.19–$24.25 (footnote indicates varying prices).
• Shares acquired: 48,400 shares; total transaction value ≈ $1,172,974.
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: Reporter states the price is an average weighted price and will provide a breakdown of shares purchased at each price upon request by the SEC, issuer, or a security holder.
• Filing timeliness: Reported for the same date as the transaction (no late filing indicated).

Context

• This was an open-market purchase by a company director. Purchases by insiders are often watched by investors as a signal of personal investment in the company, but the filing itself does not state the insider’s motive. No options exercise, gift, or tax-withholding events are reported in this filing.